Prostate-Specific Antigen Testing: Good or Bad?. (11th February 2015)

• Record Type: Journal Article
• Authors: Albertsen, Peter C.
• Is Part Of: Oncologist. Volume 20:Number 3(2015)
• Page Start: 233
• Page End: 235
• Publication Date: 2015-02-11
• Subjects: Oncology -- Periodicals; Tumors -- Periodicals; Cancérologie -- Périodiques; Tumeurs -- Périodiques; Oncology; Tumors; Neoplasms; Electronic journals; Periodicals; Periodicals; 616.994
• DOI: 10.1634/theoncologist.2015-0019
• Languages: English
• ISSNs: 1083-7159

Abstract

Abstract : Prostate-specific antigen (PSA) screening is not the panacea that enthusiasts hoped for, but it is not worthless. Men who have elevated PSA need to be aware that a prostate biopsy can identify both clinically significant and insignificant cancers and that intervention can affect quality of life. The oncologist can provide expert guidance, but once a patient understands the risks and benefits, only he can make the choice to be screened or not.